Bendtsen, Magnus Grønlund http://orcid.org/0009-0001-4858-4186
Hitz, Mette Friberg http://orcid.org/0000-0003-2195-8552
Funding for this research was provided by:
Amgen (307925+307926)
Article History
Received: 22 December 2023
Accepted: 13 February 2024
First Online: 26 March 2024
Declarations
:
: Mette Friberg Hitz has received grants from Amgen and UCB Nordic. Speaker honorarium from UCB and Amgen and participation in Advisory Boards with UCB and Novo Nordic. Magnus Grønlund Bendtsen has received speaker honorarium from UCB Nordic, Gedeon Richter Nordic, and Novo Nordisk.
: Informed consent from the patients was not obtained, as the study was approved as a quality assurance/development study with retrospective collection of data and no intervention by the local data committee (REG-145-2021) and the the hospital’s board of directors.